$CL

Hedge Funds Think Colgate-Palmolive Is One of the Best Dividend King Stocks To Buy

Colgate-Palmolive (CL) is a dividend king with a 2.5% yield, 63 years of consecutive dividend increases, and strong market shares in oral care and pet nutrition. Hedge funds rank it among top dividend stocks, but its valuation is high at 21x forward earnings. The company's stability and cash flow support dividends, but investors must assess its premium pricing and future growth prospects.

Original reporting
Published Oct 9, 2026, 2:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 9, 2026, 2:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$CL
Neutral
high confidence
Mentioned
$CL
Relevance
4/10
AlphAI data visualization · based on finance.yahoo.com
Decision brief

The 30-second read

$CLNeutralLow
01

Why it matters

The dividend announcement provides fresh data for dividend‑oriented investors, but the high payout ratio and modest yield may limit immediate buying interest.

02

Market read

Provides a fresh dividend announcement for a large, stable consumer‑staples company, offering modest trading relevance for dividend‑focused strategies.

03

What to watch

Potential upside from cost‑control initiatives or growth in pet‑nutrition could improve cash generation and support dividend sustainability.

Relevance 4/10Novelty 4/10Timing: post‑announcement of dividend

Background

The article reviews Colgate-Palmolive's dividend history, payout ratios, valuation multiples, and compares it to peers like Procter & Gamble.

Company-level read

Ticker impact

$CLNeutralHigh confidence
Context

Colgate-Palmolive announced a quarterly dividend of $0.53 per share (annual $2.12) in September 2026, with an 84% earnings payout ratio and 44% free‑cash‑flow payout ratio.

Expected impact

potential modest downside as investors weigh the high payout ratio against the modest 2.5% yield

Evidence & confidence

Dividend size is modest and the stock trades at a premium; the high earnings payout ratio raises concerns about sustainability, likely limiting upside.

Market effects

May prompt a review of other consumer‑staples dividend stocks as investors compare yields and payout ratios.

Limited to U.S. consumer‑staples sector; no broader regional effect.

Low global impact; primarily relevant to dividend‑focused investors.

Counterpoint

Despite the premium valuation, the stable cash flow and dividend track record could support a buy‑the‑dip strategy if the stock corrects.

Key entities

  • Colgate-Palmolive Company

    U.S. consumer‑staples firm (ticker CL) that announced its latest dividend.

Related articles

High

Here's why Colgate-Palmolive shares jumped over 7% on Friday

Colgate-Palmolive (India) shares rose 8% after the GST Council recommended expanding input tax credit eligibility. The changes aim to reduce taxes and ease working-capital pressures. The company also benefited from a GST rate cut on oral-care products last year. Analysts estimate cost impacts from the inverted duty structure. The company reported strong revenue growth in Q1 FY27 and outlined growth strategies at an investor day.

$CLMedAI 8/10

Colgate-Palmolive (CL) is Making Room for Its Stronger Growth Engines. Will it Pay Off?

Colgate-Palmolive (CL) is considering selling mass-market personal care brands, including Softsoap and Speed Stick, for over $1 billion. The company aims to streamline its portfolio, focusing on higher-margin categories like Hill’s Pet Nutrition and international markets. Q2 2026 net sales rose 4.9% to $5.36 billion, with operating cash flow at $1.74 billion. Proceeds could reduce debt and optimize capital structure, but divestments may impact short-term revenue and earnings predictability.

$CLMed

Piper Sandler cuts Colgate-Palmolive stock price target on cost pressures

Piper Sandler reduced its price target for Colgate-Palmolive (CL) to $95 from $98, citing cost pressures from elevated oil prices and inventory headwinds. The firm maintained an Overweight rating and a 2026 EPS estimate of $3.85, but lowered its 2027 EPS estimate to $4.12 from $4.23. CL trades at $87.47 with a P/E ratio of 34.6 and a gross profit margin of 60%. Other analysts have maintained positive outlooks, with RBC and UBS setting higher price targets.

$CLMedAI 8/10

Colgate-Palmolive Explores Sale Of Softsoap, Irish Spring, Speed Stick Brands: Report

Colgate-Palmolive (CL) is exploring the sale of brands like Softsoap, Irish Spring, and Speed Stick, potentially fetching over $1 billion. The company is working with Goldman Sachs (GS) on the divestiture. Personal care accounted for 17% of CL's 2025 net sales, which totaled $20.38 billion. The move is part of a broader productivity and restructuring program aimed at generating annual pre-tax savings of $200 million to $300 million by 2028.